Existing clients

Log in to your client extranet for free matter information, know-how and documents.

Client extranet portal

Staff

Mills & Reeve system for employees.

Staff Login
04 Jun 2026
2 minutes read

Care home acquisitions attract further scrutiny

Following its recent review of four completed acquisitions of over 600 operational care homes by Welltower Inc, the Competition and Markets Authority (CMA) has opened another merger inquiry into a completed acquisition in the care homes sector. You can read our earlier commentary on the Welltower acquisitions here and here.

The continued scrutiny of the sector is further evidence of the CMA prioritising work in areas that promote household prosperity and protect consumers, in line with its Annual Plan for 26/27.  

This time, the CMA is looking into the acquisition of Hutchinson Homes Limited by Y3 Holdings Limited, part of the Healthcare Ireland group. Healthcare Ireland is an established care home operator, with a portfolio of homes providing residential, nursing and specialist care services, primarily in Northern Ireland. Hutchinson Homes is a family‑run operator with several nursing and residential care homes, also located in Northern Ireland.

The CMA’s interest reflects the fact that the parties overlap in the provision of care home services in Northern Ireland, raising potential concerns about a reduction in local competition in areas where both groups operate. As is common where a merger has already completed before the CMA begins its investigation, the CMA’s first step has been to impose an Initial Enforcement Order (IEO) on the parties.

The IEO requires the parties to hold their businesses separate and refrain from further integration while the CMA conducts its inquiry. This includes restrictions on operational integration, management changes and the sharing of commercially sensitive information, with the aim of preserving the pre‑merger competitive position pending the CMA’s assessment. IEOs can be very burdensome in practice, as they prevent planned synergies or exit strategies from being realised and include significant compliance and reporting obligations.

The CMA has not yet confirmed the statutory timetable for its Phase 1 investigation. However, the opening of this case underlines their continued focus on the care sector, particularly where transactions may affect competition at a local level, and the importance of considering competition issues as part of deal planning.

Need more information?

Our specialists in the health and care sector can provide clear, practical insight into the CMA’s processes and would be happy to discuss the implications of this case. 

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.